Codexis, Inc. (LON:0I0X)
2.809
+0.128 (4.77%)
At close: Aug 1, 2025
Codexis Revenue
Codexis had revenue of $7.54M USD in the quarter ending March 31, 2025, a decrease of -55.82%. This brings the company's revenue in the last twelve months to $49.82M, down -32.89% year-over-year. In the year 2024, Codexis had annual revenue of $59.35M, down -15.39%.
Revenue (ttm)
$49.82M
Revenue Growth
-32.89%
P/S Ratio
4.36
Revenue / Employee
$264.97K
Employees
188
Market Cap
168.24M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 59.35M | -10.80M | -15.39% |
Dec 31, 2023 | 70.14M | -68.45M | -49.39% |
Dec 31, 2022 | 138.59M | 33.84M | 32.30% |
Dec 31, 2021 | 104.75M | 35.70M | 51.69% |
Dec 31, 2020 | 69.06M | 598.00K | 0.87% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Codexis News
- 2 months ago - Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - GlobeNewsWire
- 2 months ago - Codexis to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Codexis, Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Codexis reiterates $64M-$68M 2025 revenue guidance as ecosynthesis platform gains traction with CDMOs - Seeking Alpha
- 2 months ago - Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Codexis Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Preview: Codexis's Earnings - Benzinga
- 3 months ago - Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting - GlobeNewsWire